Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL SOFT GELS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL SOFT GELS MARKETSIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMAPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 DEMAND AND SUPPLY-SIDE VARIABLES
2.2.8 TOP TO BOTTOM ANALYSIS
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL SOFT GELS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 VALUE CHAIN ANALYSIS
5.2 SUPPLY CHAIN ANALYSIS
5.3 IMPORT-EXPORT ANALYSIS
5.4 PORTER’S FIVE FORCES ANALYSIS
5.4.1 BARGAINING POWER OF SUPPLIERS
5.4.2 BARGAINING POWER OF BUYERS/CONSUMERS
5.4.3 THREAT OF NEW ENTRANTS
5.4.4 THREAT OF SUBSTITUTE PRODUCTS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 RAW MATERIAL SOURCING ANALYSIS
5.6 OVERVIEW OF TECHNOLOGICAL INNOVATIONS
5.7 INDUSTRY TRENDS AND FUTURE PERSPECTIVE
5.8 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS
5.9 FACTORS INFLUENCING PURCHASING DECISION OF END-USERS
6 IMPACT OF ECONOMIC SLOW DOWN ON MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON SUPPLY CHAIN
6.3 IMPACT ON SHIPMENT
6.4 IMPACT ON COMPANY’S STRATEGIC DECISIONS
7 REGULATORY FRAMEWORK AND GUIDELINES
8 PRICING INDEX (PRICE AT B2B END & PRICES AT FOB)
9 PRODUCTION CAPACITY OF KEY MANUFACTURERES
10 BRAND OUTLOOK
10.1 COMPARATIVE BRAND ANALYSIS
10.2 PRODUCT VS BRAND OVERVIEW
11 GLOBAL SOFT GELS MARKET, BY PRODUCT, 2022-2031, (USD MILLION)
11.1 OVERVIEW
11.2 GELATIN-BASED/ANIMAL-BASED
11.3 NON-ANIMAL-BASED
12 GLOBAL SOFT GELS MARKET, BY APPLICATION, 2022-2031, (USD MILLION)
12.1 OVERVIEW
12.2 ANTACID AND ANTI-FLATULENT PREPARATION
12.3 ANTI-ANEMIC PREPARATIONS
12.4 ANTI-INFLAMMATORY DRUGS
12.5 ANTIBIOTIC AND ANTIBACTERIAL DRUGS
12.6 COUGH AND COLD PREPARATIONS
12.7 HEALTH SUPPLEMENT
12.8 VITAMIN AND DIETARY SUPPLEMENT
12.9 PREGNANCY
12.1 OTHERS
13 GLOBAL SOFT GELS MARKET, BY END-USE, 2022-2031, (USD MILLION)
13.1 OVERVIEW
13.2 PHARMACEUTICAL COMPANIES
13.3 NUTRACEUTICAL COMPANIES
13.4 COSMECEUTICAL COMPANIES
13.5 CONTRACT MANUFACTURING ORGANIZATION
14 GLOBAL SOFT GELS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14.5 MERGERS & ACQUISITIONS
14.6 NEW PRODUCT DEVELOPMENT & APPROVALS
14.7 EXPANSIONS & PARTNERSHIP
14.8 REGULATORY CHANGES
15 GLOBAL SOFT GELS MARKET, BY GEOGRAPHY, 2022-2031, (USD MILLION)
OVERVIEW (ALL SEGMENTATION PROVIDED ABOVE IS REPRESNTED IN THIS CHAPTER BY COUNTRY)
15.1 NORTH AMERICA
15.1.1 U.S.
15.1.2 CANADA
15.1.3 MEXICO
15.2 EUROPE
15.2.1 GERMANY
15.2.2 U.K.
15.2.3 ITALY
15.2.4 FRANCE
15.2.5 SPAIN
15.2.6 SWITZERLAND
15.2.7 NETHERLANDS
15.2.8 BELGIUM
15.2.9 RUSSIA
15.2.10 TURKEY
15.2.11 REST OF EUROPE
15.3 ASIA-PACIFIC
15.3.1 JAPAN
15.3.2 CHINA
15.3.3 SOUTH KOREA
15.3.4 INDIA
15.3.5 AUSTRALIA
15.3.6 SINGAPORE
15.3.7 THAILAND
15.3.8 INDONESIA
15.3.9 MALAYSIA
15.3.10 PHILIPPINES
15.3.11 REST OF ASIA-PACIFIC
15.4 SOUTH AMERICA
15.4.1 BRAZIL
15.4.2 ARGENTINA
15.4.3 REST OF SOUTH AMERICA
15.5 MIDDLE EAST AND AFRICA
15.5.1 SOUTH AFRICA
15.5.2 UAE
15.5.3 SAUDI ARABIA
15.5.4 KUWAIT
15.5.5 REST OF MIDDLE EAST AND AFRICA
16 GLOBAL SOFT GELS MARKET, SWOT & DBMR ANALYSIS
17 GLOBAL SOFT GELS MARKET, COMPANY PROFILES
17.1 SIRIO EUROPE GMBH CO KG
17.1.1 COMPANY OVERVIEW
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 CAPTEK SOFTGEL INTERNATIONAL INC.
17.2.1 COMPANY OVERVIEW
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENTS
17.3 FUJI CAPSULE
17.3.1 COMPANY OVERVIEW
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENTS
17.4 PROCAPS LABORATORIES, INC.
17.4.1 COMPANY OVERVIEW
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 LONZA
17.5.1 COMPANY OVERVIEW
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 AENOVA GROUP
17.6.1 COMPANY OVERVIEW
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENTS
17.7 EUROCAP
17.7.1 COMPANY OVERVIEW
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 CATALENT, INC.
17.8.1 COMPANY OVERVIEW
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENTS
17.9 GUANGDONG YICHAO BIOLOGICAL CO., LTD.
17.9.1 COMPANY OVERVIEW
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 ELNOVA PHARMA
17.10.1 COMPANY OVERVIEW
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENTS
17.11 GELTEC
17.11.1 COMPANY OVERVIEW
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENTS
17.12 SOFT GEL TECHNOLOGIES, INC
17.12.1 COMPANY OVERVIEW
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENTS
17.13 SOFTCAPS (TITANIUM TECHNOLOGIES INDIA PVT LTD).
17.13.1 COMPANY OVERVIEW
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
18 RELATED REPORTS
19 CONCLUSION
20 QUESTIONNAIRE
21 ABOUT DATA BRIDGE MARKET RESEARCH
